PL3191099T3 - Pochodne pirydopirymidyn - Google Patents

Pochodne pirydopirymidyn

Info

Publication number
PL3191099T3
PL3191099T3 PL15840871T PL15840871T PL3191099T3 PL 3191099 T3 PL3191099 T3 PL 3191099T3 PL 15840871 T PL15840871 T PL 15840871T PL 15840871 T PL15840871 T PL 15840871T PL 3191099 T3 PL3191099 T3 PL 3191099T3
Authority
PL
Poland
Prior art keywords
pyridopyrimidines
derivatives
Prior art date
Application number
PL15840871T
Other languages
English (en)
Inventor
Gilberto De Nucci
Original Assignee
Biolab Sanus Farmacéutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Sanus Farmacéutica Ltda filed Critical Biolab Sanus Farmacéutica Ltda
Publication of PL3191099T3 publication Critical patent/PL3191099T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL15840871T 2014-09-12 2015-09-11 Pochodne pirydopirymidyn PL3191099T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462049506P 2014-09-12 2014-09-12
EP15840871.6A EP3191099B1 (en) 2014-09-12 2015-09-11 Derivatives of pyridopyrimidines
PCT/BR2015/050147 WO2016037255A2 (en) 2014-09-12 2015-09-11 New pyridopyrimidines derivatives compounds

Publications (1)

Publication Number Publication Date
PL3191099T3 true PL3191099T3 (pl) 2019-07-31

Family

ID=55454107

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15840871T PL3191099T3 (pl) 2014-09-12 2015-09-11 Pochodne pirydopirymidyn

Country Status (18)

Country Link
US (2) US10280162B2 (pl)
EP (1) EP3191099B1 (pl)
JP (1) JP6661606B2 (pl)
KR (1) KR20170054408A (pl)
CN (2) CN114751905A (pl)
AR (1) AR101813A1 (pl)
AU (1) AU2015316120B2 (pl)
BR (1) BR112017004919A2 (pl)
CA (1) CA2958331C (pl)
CL (1) CL2017000582A1 (pl)
CO (1) CO2017001709A2 (pl)
ES (1) ES2701273T3 (pl)
HU (1) HUE040387T2 (pl)
IL (1) IL250968B (pl)
MX (1) MX2017003067A (pl)
PL (1) PL3191099T3 (pl)
PT (1) PT3191099T (pl)
WO (1) WO2016037255A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017523211A (ja) 2014-08-04 2017-08-17 ドレクセル ユニバーシティ 新規化合物およびそれを用いてil−1r媒介性の疾患または障害を処置するかまたは寛解させる方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313736B1 (en) * 2000-06-26 2005-07-27 Lilly Icos LLC Condensed pyrazindione derivatives as inhibitors of pde5
KR100571339B1 (ko) 2000-08-31 2006-04-17 에프. 호프만-라 로슈 아게 세포증식 억제제로서의 7-옥소 피리도피리미딘
AU2001296699A1 (en) * 2000-11-08 2002-05-21 Lilly Icos Llc Condensed pyrazindione derivatives as pde inhibitors
FR2896246B1 (fr) * 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
MX2008014689A (es) * 2006-05-23 2008-11-27 Hoffmann La Roche Derivados de piridopirimidininona.
WO2008008704A2 (en) * 2006-07-11 2008-01-17 University Of Texas Health Science Center Inhibitors of cyclic nucleotide synthesis and their use for therapy of various diseases
US7474231B2 (en) * 2006-07-12 2009-01-06 Alcatel-Lucent Usa Inc. Radio communications for vehicle speed adjustment
UY33535A (es) * 2010-08-13 2011-12-01 Biolab Sanus Farmaceutuca Limitada Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona
ES2606835T3 (es) * 2012-06-06 2017-03-28 L'oréal Compuestos activos para combatir la piel grasa

Also Published As

Publication number Publication date
KR20170054408A (ko) 2017-05-17
AU2015316120B2 (en) 2018-05-17
CA2958331A1 (en) 2016-03-17
AU2015316120A1 (en) 2017-01-12
IL250968B (en) 2020-03-31
US10280162B2 (en) 2019-05-07
PT3191099T (pt) 2018-12-18
CA2958331C (en) 2019-12-17
CN114751905A (zh) 2022-07-15
CL2017000582A1 (es) 2017-11-24
EP3191099B1 (en) 2018-11-14
CO2017001709A2 (es) 2017-03-31
MX2017003067A (es) 2017-06-14
HUE040387T2 (hu) 2019-03-28
AR101813A1 (es) 2017-01-11
US20190218216A1 (en) 2019-07-18
US20180111926A2 (en) 2018-04-26
EP3191099A2 (en) 2017-07-19
WO2016037255A3 (en) 2016-06-30
US10822333B2 (en) 2020-11-03
US20160075702A1 (en) 2016-03-17
WO2016037255A2 (en) 2016-03-17
JP2017526666A (ja) 2017-09-14
JP6661606B2 (ja) 2020-03-11
BR112017004919A2 (pt) 2017-12-12
IL250968A0 (en) 2017-04-30
CN107074847A (zh) 2017-08-18
ES2701273T3 (es) 2019-02-21

Similar Documents

Publication Publication Date Title
SG11201706729SA (en) Derivatives of sobetirome
IL263050B (en) History of Subtirum
SI3154526T1 (sl) Trdne oblike sofosbuvira
SG11201609205WA (en) Heterocyclyl-butanamide derivatives
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
EP3140315C0 (en) NEW CATH2 DERIVATIVES
IL246979A0 (en) Crystalline forms of sofosbuvir
IL248773A0 (en) History of naphthyridinedione
PL3418273T3 (pl) Pochodne flawaglin
IL248629B (en) Substances containing diheteroaryl conjugated to cycloalkyl and their uses
PL3097076T3 (pl) Nowe pochodne CYP-eikozanoidowe
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
IL249130A0 (en) Preparation of piperidine-4-carbthioamide
SG11201605072VA (en) Azaindole derivative
IL250968B (en) New compounds derived from pyridopyrimidines
IL249332A0 (en) Crystalline forms of sofosbuvir